Remove Article Remove Clinic Management Remove Labelling
article thumbnail

Five Things For Pharmacists To Know About The Treatment Of Mycobacterium Tuberculosis

IDStewardship

AI-Generated Summary This article by infectious diseases pharmacist Aneeka Chavda outlines five key considerations for pharmacists in the treatment of Mycobacterium tuberculosis (TB), particularly drug-sensitive cases. At present, she is undertaking the UK-Africa AMS leadership fellowship through the Commonwealth Pharmacists Association.

article thumbnail

Antimicrobial Stewardship in the United kingdom: Perspective From A Pharmacist At A Bone & Joint Hospital

IDStewardship

In this article antimicrobial stewardship in the United Kingdom is discussed. Article posted 1 August 2022. I certainly feel more connected with my peers since the pandemic; more recently, our regional AMS group has set up a protocol for Penicillin de-labelling through our area’s medicines formulary committee. BCPS, BCIDP.

Hospitals 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

Given the proliferation and confusion of various digital health terms, this article includes a compiled glossary of core DHT terms and definitions (see Table 1). Category II: SaMD that provides information to drive clinical management of a disease or condition in a serious situation or condition and is considered to be of medium impact.

article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

Given the proliferation and confusion of various digital health terms, this article includes a compiled glossary of core DHT terms and definitions (see Table 1). Category II: SaMD that provides information to drive clinical management of a disease or condition in a serious situation or condition and is considered to be of medium impact.